In contrast, anti-CD73 Abs significantly downregulated the expression of PD-1 and CTLA-4 by CD4+ and CD8+ T cells in a murine transgenic head and neck squamous cell carcinoma (HNSCC) model, resulting in substantial reduction of tumor growth (95). Here, CD4 is linked to head and neck squamous cell carcinoma.